Newsroom

Nutrition – Absorbing Nutrients After Surgery

The digestive system is a group of organs that work together to feed the entire body by converting food into energy and basic nutrients. Food is ingested through the mouth; passed through the esophagus into the stomach; and filtered through the small intestine, pancreas and liver. Based on its particular function, each organ contributes in different ways to turn the food we eat into the nutrients we need.

By |2022-01-05T13:18:01-05:00April 8th, 2016|Coping with GIST, Integrative Medicine, Newsletter, Nutrition|

Brief from ASCO’s Clinical Cancer Advances 2016

On February 4, 2016, Life Raft Group member Noha Hussein attended the American Society of Clinical Oncology’s (ASCO) Capitol Hill Briefing on their report, “Clinical Cancer Advances 2016,” in Washington, DC at the Rayburn [...]

By |2018-10-30T09:55:28-04:00April 5th, 2016|Advocacy, News, Newsletter|

Study Finds Adjuvant Systemic Therapy with Imatinib Increasing Over Time

A recent study published in the American Journal of Clinical Oncology found that the use of adjuvant systemic therapy with imatinib for GIST has increased significantly over time, and that patients treated with the [...]

By |2018-10-30T09:55:33-04:00March 15th, 2016|Drug Treatment, News, Survival Strategies|

LRG Supports New Jersey Legislation to Limit Patient Cost Sharing

Although GIST is among the few rare diseases that has oral chemotherapy drug treatment options available to its patients, the cost of affording these life saving medications can sometimes impose deep financial hardship depending [...]

By |2018-10-30T09:55:47-04:00February 12th, 2016|Advocacy, News|

GIST Collaborative Tissue Bank: A researcher’s perspective

The Life Raft Group GIST Collaborative Tissue Bank consists of a collection of tumor specimens from a large number of patients, stored at Stanford University. The advantages of having a tissue bank for a [...]

By |2020-02-05T08:36:22-05:00February 10th, 2016|News, Newsletter, Research, Tissue Bank|

Generic Imatinib Approved in the US for CML: What does it mean for GIST patients?

On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), for CML (Chronic Myeloid Leukemia) was approved by the FDA after the Novartis patent expiration and will become available for the first time in the United States through Sun Pharmaceuticals.

By |2019-09-23T11:28:24-04:00February 10th, 2016|Drug Treatment, Generics, Gleevec, News, Newsletter|

How To S.T.O.P. Caregiver Burnout

According to a 2015 report by the  National Alliance of Caregivers, approximately 43.5 million adults in the United States provided unpaid care to an adult or child in 2015. Caregivers come from diverse demographic [...]

By |2019-10-31T13:38:50-04:00February 10th, 2016|Caregiver Support, Coping with GIST, News, Newsletter|

The Heart of the Matter: Cardiac Health for GIST Patients

The heart is at the center of the cardiovascular system, the main function of which is to pump blood throughout the body, providing tissue and organs with the oxygen and nutrients they need. To [...]

By |2019-09-20T15:37:59-04:00February 10th, 2016|GIST Education, Newsletter, Side Effects|
Go to Top